20 minutes that matter
Open Access

Emerging role of biomarkers for cardiovascular risk assessment in T2DM and optimisation of cardioprotective treatment: current evidence and future trends

15 September 2022, from 18:00 to 19:00 CET

Organiser: Heart Failure Association of the ESC (HFA)
Topic: Diagnostic Methods
Host: Professor P. Seferovic (Belgrade, RS)
Speakers: Doctor A. Bayes Genis (Badalona, ES) , Professor A. Mebazaa (Paris, FR)


This content is currently on OPEN ACCESS

Sign in to view the resources

Want to watch the next episode?

Sign up and we'll remind you to tune in

About the contributors

Professor Petar Seferovic

Belgrade University, Faculty of Medicine, Belgrade (Serbia)

Role: Host

Doctor Antonio Bayes Genis

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)

Role: Speaker

Professor Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)

Role: Speaker

This platform is supported by

logo Novo Nordisk